AMLOGENYX
Live / Applied — First extension granted (statement of use) (as of 03 Oct 2025)
What this means for you
Not registered yet, but its 11 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98745222
- Mark type
- Stylized text
- Filed
- 11 Sept 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases and disorders, neurological diseases and disorders, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; new product design services in the field of gene therapy; product development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of neurological and genetic diseases and disorders; medical and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of gene therapies
Owner
- Amlogenyx Inc., Novato, CA, US
- Amlogenyx Inc., Novato, CA, US
Prosecution history
- 04 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2025 — SOU EXTENSION 1 GRANTED
- 03 Oct 2025 — SOU EXTENSION 1 FILED
- 03 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Mar 2025 — NON-FINAL ACTION E-MAILED
- 14 Mar 2025 — NON-FINAL ACTION WRITTEN